Adit Ginde, MD MPH,
University of Colorado School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Adit Ginde, MD MPH, as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:59 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04860518 · Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With COVID-19Faron Pharmaceuticals Ltd · terminated · Covid19 · principal investigator
- Ph3NCT04534959 · Strategy to Avoid Excessive Oxygen for Critically Ill Trauma PatientsUniversity of Colorado, Denver · active not recruiting · Critical Illness, Wounds and Injury, Disease Attributes
- Ph3NCT04534972 · Strategy to Avoid Excessive Oxygen in Major Burn PatientsUniversity of Colorado, Denver · active not recruiting · Critical Illness, Wounds and Injury, Disease Attributes
- N/ANCT03789396 · Pilot Study of Targeted Normoxia in Critically Ill Trauma PatientsUniversity of Colorado, Denver · completed · Trauma, Critical Illness, Oxygen Toxicity
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.